The new pacemakers provide longer battery life and easier programming than prior Micra pacemakers, while still delivering the many benefits of leadless pacing.
The Paragonix SherpaPak Cardiac Transport System is associated with improved outcomes compared with the use of traditional cold storage in LVAD patients.
Viz.ai has submitted a de novo classification request to the FDA for a new AI algorithm to identify and triage patients suspected of suffering from HCM.
The companies are offering healthcare organizations a holistic program that goes beyond the traditional break-fix approach to medical device maintenance.